12/24/2008
»
Explore AMCP's Many Professional Resources Quickly and Easily
AMCP members have the inside track on information critical to their decision making. And best of all, these resources are only a click away!
Explore AMCP Publications for the Academy's well-known and often-cited documents, like the Format for Formulary Submissions and Sound Medication Therapy Management Programs, V2.0.
Visit Statistical Data Resources, where you’ll find The Managed Care Digest Series, containing useful information from senior care to managed care trends, including established benchmarks and opportunities for MCOs; The Injectable Digest, including Biotechnology Innovation, Specialty Product Development and Specialty Pharmacy Management...and much more!
Check out the Knowledge Links, a library of guidelines from AHRQ, CMS, FDA, AMCP and others!
Stay on top of your profession with help from AMCP.
|
12/17/2008
»
Academic Detailing and Comparative Effectiveness Proposals Supported
AMCP has posted letters of support for two bills introduced earlier this year in Congress: the “Independent Drug Education and Outreach Act of 2008,” which would provide grants or contracts for prescription drug education and outreach programs for health care providers and their patients, and the “Comparative Effectiveness Research Act of 2008,” which would create an institute that would conduct specific research on the effectiveness of alternative health care treatments. To read the letters, click on the bill titles.
|
10/29/2008
»
Press Release: Survey Shows Negative Impact of Medicare Part D "Classes of Clinical Concern"
In a new report issued today, the Academy of Managed Care Pharmacy has released data that shows the financial impact of the mandate contained within Section 176 of the Medicare Improvement for Patients and Providers Act of 2008 stipulating that all Medicare Part D formularies contain all drugs in the "six protected classes."
|
10/29/2008
»
New Report on Effects of Formulary Mandates Released
AMCP has just released a report on the financial impact of the mandate to include all drugs from the six "protected classes" on Medicare Part D formularies, included in Section 176 of the Medicare Improvements for Patients and Providers Act of 2008. The stipulations contained in Section 176 will affect Part D formularies to be submitted for approval in the spring of 2009. To read the report, click here.
|
